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Hypothalamic microRNAs flip the switch for fertility
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Reproduction, in mammals, is finely regulated by the 
hypothalamic-pituitary-gonadal axis (HPG) and driven, by 
a complex neural network within the hypothalamus that 
converges onto GnRH-producing neurons, the master 
regulators of gonadotropin secretion [1]. The correct 
development of the GnRH system as well as a finely 
programmed postnatal increase in GnRH production and 
secretion are essential for sexual maturation and puberty 
onset [1]. However, despite the identification of several 
factors known to influence GnRH production and release, 
the molecular mechanisms controlling the postnatal 
increase in GnRH expression and its timing have remained 
a mystery until now. We have recently made a significant 
advance in understanding these processes by uncovering 
a specific set of microRNAs, embedded in the genetic 
network controlling GnRH transcription, that drive the 
infantile switch from the repression to the induction of 
GnRH expression [2].
MicroRNAs are small, non-coding RNAs that fine-
tune gene expression at the post-transcriptional level. 
Considered major players in epigenetics, microRNAs, 
together with transcription factors, form integrated gene 
regulatory networks that can control complex cellular 
processes with extreme temporal precision [3], making 
them ideal candidates for the molecular control of the 
timing of puberty. Converging evidence supports a role for 
microRNAs in mouse gonadal [4] and pituitary function 
[5], while a recent human genome-wide association 
study has highlighted a link between age at puberty and 
a genetic locus controlling the expression of a specific 
microRNA family [6]. However there has been no direct 
evidence until now of the functional implication of 
microRNAs in the hypothalamic control of puberty, nor of 
the mechanisms that could subtend this process.
Our results show that, during an infantile “critical 
period” lasting just a few days, a dramatic switch in the 
microRNA expression pattern of GnRH neurons inverts 
the balance between inductive and repressive signals, 
triggering increased hypothalamic GnRH expression and 
controlling the crucial transition from the early infantile 
phase, when its levels are low, to the GnRH-fuelled run-up 
to puberty (Figure 1) [2]. This infantile “critical period” 
corresponds to a centrally-driven gonad-independent 
activation of the HPG axis and the resulting surge in 
gonadotropin levels (on postnatal days 10-16 in mice). 
This phenomenon, known as “mini-puberty” in humans, 
is the first of three activational periods that prime the HPG 
axis for puberty and adult fertility, setting in motion, for 
example, the growth of the first wave of ovarian follicles 
set to ovulate at puberty in females and the development 
of the testes in males [7]. 
Specifically, we have shown that during this 
critical period, a switch in the expression of several 
microRNA species in the hypothalamus in turn flips a 
switch in a multilayered array of GnRH gene activators 
and repressors, permitting the sustained increase of the 
neurohormone required for subsequent sexual maturation 
[2]. Two microRNA species act as the linchpins of this 
process: the miR-200/429 family, which is not only 
upregulated during the critical period but selectively 
enhanced in GnRH neurons, and miR-155, which appears 
to act on other hypothalamic cell types as well, and 
mediates, for example, the effects of a release of nitric 
oxide known to occur concomitantly upstream of GnRH 
neurons . We have also pinpointed several genes targeted 
directly or indirectly by miR-155 and miR-200/429, 
whose repression (e.g. Cebpb and Zeb1) or activation 
(e.g. Pou2f1 and Meis1, which are both targets for Zeb1) 
is required for the normal increase of GnRH expression 
from “mini-puberty” onwards. Selectively blocking miR-
200/429 binding to the 3’UTR of the Zeb1 transcript in 
the hypothalamus during the infantile period (between P7 
and weaning) suppresses GnRH promoter activity at the 
cellular level and leads to abnormalities in the onset of 
puberty. Interestingly, the microRNA-gene micronetworks 
that we have identified as sustaining the postnatal increase 
in GnRH expression also appear to be at work during 
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Figure 1: MicroRNA-gene network controlling GnRH 
transcription: the timely switch in GnRH expression from 
repression to induction leads to puberty onset.
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adulthood, since the blockade of miR-200/429/Zeb1 
binding in the hypothalamus impacts estrous cyclicity in 
adult female mice. 
These results raise the intriguing possibility that 
the microRNA-dependent epigenetic regulation of GnRH 
secretion could underlie the pathophysiology of human 
congenital hypogonadotropic hypogonadism (CHH) 
when no mutations are found in known CHH genes 
[8]. Exploring the putative contribution of mutations 
in these microRNA-gene networks could thus hold 
therapeutic potential for disorders of puberty and fertility 
of hypothalamic origin (e.g. by using small molecules 
that interfere with or restore microRNA action on target 
genes).
While the identification of this unprecedented 
microRNA-based genetic network controlling GnRH 
transcription represents a clear advance in our 
understanding of the molecular basis of puberty, it 
raises new questions and challenges. What triggers this 
developmental switch in microRNA expression in GnRH 
neurons after birth? What roles do hypothalamic wiring; 
hormones and the environment play in this process? And 
finally, to what extent can pharmacological interventions 
modulate this process, and what are their limitations?
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